Olivia
Online
Nuvectis Pharma
@Nuvectis
Innovative precision medicine for the treatment of complement-related conditions and oncology. NASDAQ: $NVCT.
Joined May 2024
166 Following
94 Followers
55 Posts
Nuvectis Announces NXP200 Granted Breakthrough Therapy Designation in China for BRAF V600-Mutant, Recurrent or Progressive, High-Grade Glioma
Read the full release https://t.co/d6Zz0r9xHW $NVCT
$NVCT Nuvectis Pharma To Participate in Upcoming Investor Conferences
Read the Full Press Release π https://t.co/qz1DREtywo
$NVCT Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights
Read the Full Press Release π https://t.co/Wmsel5dwpJ
$NVCT Correction: (Title Correction) Nuvectis Announces Marketing Approval of Ciprocopan (NXP100) in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors
Read the Full Press Release π https://t.co/cpaB31L86X
$NVCT Ciprocopan (NXP100) Receives Marketing Approval in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors
Read the Full Press Release π https://t.co/m9dQTgUmGZ
$NVCT Nuvectis Pharma Announces Pricing of $100 Million Public Offering of Common Stock
Read the Full Press Release π https://t.co/EZZ6W90Lc1
$NVCT Nuvectis Pharma Announces Proposed Public Offering of Common Stock
Read the Full Press Release π https://t.co/EpXFJ2yVh3
$NVCT Nuvectis Announces Strategic Portfolio Expansion via License Agreement for Ex-China Rights with Haisco Pharmaceutical Group for Two Potentially Best-In Class Clinical-Stage Compounds
Read the Full Press Release π https://t.co/MZ7Pm4TYf6
$NVCT Nuvectis Pharma, Inc. To Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
Read the Full Press Release π https://t.co/StwKvZ4o3Q
$NVCT Nuvectis Pharma, Inc. Reports First Quarter 2026 Financial Results and Business Highlights
Read the Full Press Release π https://t.co/7Sx6Ygk4FG
$NVCT Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2026 American Association for Cancer Research Meeting
Read the Full Press Release π https://t.co/Y06lE2ZdFw
$NVCT Nuvectis Pharma, Inc. Reports 2025 Financial Results and Business Highlights
Read the Full Press Release π https://t.co/D3eEJB7Tm5
$NVCT Nuvectis Pharma Announces the Initiation of the Phase 1b Study of NXP900 in Combination with Osimertinib in Patients with NSCLC
Read the Full Press Release π https://t.co/rGaWUbBUCE
$NVCT Nuvectis Pharma to Host a Virtual Key Opinion Leader Meeting to Discuss the NXP900 Phase 1b Program in Advanced Solid Tumors, Including the Combination with Osimertinib in NSCLC
Read the Full Press Release π https://t.co/nj5Ff7I1pa
$NVCT CORRECTION: Nuvectis Pharma, Inc. Reports Third Quarter 2025 Financial Results and Business Highlights
Read the Full Press Release π https://t.co/m61vvypZjx
$NVCT Nuvectis Pharma, Inc. Reports Third Quarter 2025 Financial Results and Business Highlights
Read the Full Press Release π https://t.co/WbGr6ChHFx
$NVCT Nuvectis Pharma Provides Poster Presentation Highlights for NXP900 from the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Read the Full Press Release π https://t.co/2BmbjoDgwH
$NVCT Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Read the Full Press Release π https://t.co/1kk91olkds
$NVCT Nuvectis Pharma Appoints Biotech Executive Juan Sanchez, MD, to the Board of Directors
Read the Full Press Release π https://t.co/7dAYZYVDth
$NVCT Nuvectis Pharma to Participate at the H.C. Wainwright 27th Annual Global Investment Conference
Read the Full Press Release π https://t.co/8GGhtUY4CH
Last Seen Users on Sotwe
ΰΈ£ΰΈΈΰΉΰΈΰΈͺΰΈΉΰΈΰΈ§ΰΈ±ΰΈ’ 60 ΰΈΰΈΆΰΉΰΈ
Seen from Thailand
Youngboy420
Seen from Turkey
Ψ£ΨΨ―Ψ« Ψ§ΩΩΩΨ―ΩΩΩΨ§Ψͺ Ψ§ΩΩ
Ψ«ΩΨ±Ψ© ΩΨ§ΩΨ¬ΩΨ³ΩΨ© Ψ§ΩΩ
Ψ΅Ψ±ΩΨ©
Seen from Egypt
AltayYalΓ§Δ±ndaΔ
Seen from Turkey
Εehrin YabancΔ±sΔ±
Seen from Turkey
ΩΨΩ Ψ¬Ψ―Ω Ψ³ΩΨ―Ψ§ΩΩ Ω
Ω ΩΨ³ΩΨ§
GETS GRANDMA
Seen from Netherlands
Naked Fit Men
Seen from Poland
ππππ ππ ππ ππππππππ§¬β¨
Recep Δ°vedikk
Seen from Turkey
Most Popular Users
Elon Musk
@elonmusk
241.7M followers
Barack Obama
@barackobama
119M followers
Cristiano Ronaldo
@cristiano
114.4M followers
Donald J. Trump
@realdonaldtrump
111.9M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
83.9M followers
Lady Gaga
@ladygaga
75.4M followers
Virat Kohli
@imvkohli
73.4M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.4M followers
Bill Gates
@billgates
65.2M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers